Bioaffinity Technologies vs Charming Medical
Bioaffinity Technologies is the larger business, with $6.2m of revenue in fiscal 2025 against $4.8m for Charming Medical (1.3 times as much). Charming Medical grew faster (-22.7% against -34.2%). Charming Medical kept more of each dollar of sales as profit: a net margin of -0.5% against -242.0%. Bioaffinity Technologies carries less debt relative to equity (2.0% against 7.2%).
| Latest fiscal year | Bioaffinity TechnologiesBIAF, 2025 | Charming MedicalMCTA, 2026 |
|---|---|---|
| Revenue | $6.2m | $4.8m |
| Revenue growth | -34.2% | -22.7% |
| Net income | −$14.9m | −$22,648 |
| Operating margin | -171.6% | -0.6% |
| Net margin | -242.0% | -0.5% |
| Return on equity | — | -0.9% |
| Free cash flow | −$9.4m | −$1.6m |
| Cash | $6.4m | $4.7m |
| Total debt | $146,474 | $371,598 |
| Debt to equity | 2.0% | 7.2% |
| Dividend per share | — | — |
| Dividend yield | — | — |
| Share buybacks | — | — |
| Employees | 57 | — |
| Market value | $21.0m | $474m |
| Price vs our value range | — | — |
| Moat score | — | — |
| Insider trades, 12 months | 0 buys, 0 sales | 0 buys, 0 sales |